help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kukreja, S. C.
Right arrow Articles by Johnson, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kukreja, S. C.
Right arrow Articles by Johnson, P. A.

Journal of Clinical Endocrinology & Metabolism, Vol 51, 167-169, Copyright © 1980 by Endocrine Society

ARTICLES

Elevated nephrogenous cyclic AMP with normal serum parathyroid hormone levels in patients with lung cancer

SC Kukreja, WP Shemerdiak, TE Lad and PA Johnson

Total and nephrogenous urinary cyclic AMP (cAMP), serum Parathyroid Hormone (PTH) and ionized calcium (Ca) levels were determined in 8 normal subjects, and 16 normocalcemic and 9 hypercalcemic patients with lung cancer. Total and nephrogeneous cAMP levels were significantly increased in both normocalcemic and hypercalcemic lung cancer patients, as compared to normal subjects. There was no significant correlation between serum PTH and total or nephrogenous cAMP in the cancer group. The factors responsible for the elevated nephrogenous cAMP in the lung cancer patients are not known.


This article has been cited by other articles:


Home page
 ChestHome page
S. G. Spiro, M. K. Gould, and G. L. Colice
Initial Evaluation of the Patient With Lung Cancer: Symptoms, Signs, Laboratory Tests, and Paraneoplastic Syndromes: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 149S - 160S.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
L. Suva, G. Winslow, R. Wettenhall, R. Hammonds, J. Moseley, H Diefenbach-Jagger, C. Rodda, B. Kemp, H Rodriguez, E. Chen, et al.
A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression
Science, August 21, 1987; 237(4817): 893 - 896.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1980 by The Endocrine Society